UniquePerioSignature™ uses saliva-based qPCR technology to detect and quantify five targeted periodontal pathogens from a simple saliva sample. Receive quantitative results in as little as 2 business days to support clinical assessment and patient management.
ADVANCED PERIODONTAL SALIVA TESTING FOR DENTAL PRACTICES
Stop Guessing.
Start Testing.
Know the your patient's pathogen profile. Support informed care.
CLIA-CERTIFIED LAB
qPCR TECHNOLOGY
RESULTS IN 2 BUSINESS DAYS
COMPETITIVE PRICING
The Science
Meet the UniquePerioSignature™ Panel
Less than 1 mL of saliva. Five pathogens detected and quantified. A full microbial picture, ready for clinical action in 2 business days.
Detects What X-Rays Can't
Detect and quantify key pathogens associated with periodontal disease. Identify elevated periodontal pathogen levels that may be present before radiographic changes become apparent. By the time changes show on an X-ray, the disease has already progressed past early intervention.
Targets the Right Bacteria
Our highly sensitive and specific qPCR technology accurately identifies and quantifies targeted periodontal pathogens, providing actionable molecular insights for individualized patient care.
AI-assisted Clinical Decision Support
Each report includes quantitative results for each targeted pathogen, interpretive clinical insights, and supporting scientific references to assist qualified healthcare professionals in developing individualized treatment plans.
Smart Imbalance Detection
We don't overwhelm you with a complex map of your entire microbiome. Instead, we test for the key "bad actor" pathogens that act as a direct proxy for oral dysbiosis, giving you a clear look at whether your oral ecosystem is out of balance.
Actionable Insights
Understand the bacterial profile identified in the patient's saliva sample, not generic averages.
Clinical Decision Support
Our platform provides clinicians with AI-assisted clinical decision support optimized for individual patient profiles.
Precision Care Support
Take control with evidence-informed clinical considerations designed to support the patient's microbial profile and overall clinical assessment, and track your progress over time.
HEALTHIER PATIENTS. STRONGER PRACTICE.
WHY IT MATTERS
Oral pathogens may have effects beyond the oral cavity. A growing body of scientific research has identified associations between periodontal pathogens and systemic conditions, including cardiovascular disease, diabetes, and Alzheimer's disease. The UniquePerioSignature™ Panel provides molecular information to support comprehensive periodontal assessment by qualified healthcare professionals.
STRENGTHEN PATIENT TRUST
Show patients hard data, not just a clinical opinion.
SUPPORT CLINICAL DOCUMENTATION
Document objective findings before treatment decisions, not after.
PERSONALIZED CLINICAL DECISION SUPPORT
Move beyond generic periodontal protocols for every patient.
MONITOR CHANGES IN PATHOGENS LEVEL
Retest to evaluate changes in measured pathogen levels over time
WHAT'S TESTED
Comprehensive. Precise. Actionable.
One saliva sample screens for the five key pathogens associated with periodontal disease, giving you and your patient a complete clinical picture.
Five Key Pathogens
Detects and quantifies five clinically relevant periodontal bacterial species (Aa, Pg, Td, Tf, and Pi) associated with periodontal disease and oral microbial dysbiosis. Unlike standard dental exams that rely on visual assessment alone, the UniquePerioSignature™ Panel identifies exactly which pathogens are present and at what levels, giving you and your clinician a precise, data-backed picture of what is actually happening in your mouth.
Early-Stage Detection
Catches microbial imbalance before bone loss appears on X-rays. By the time radiographic evidence of damage becomes visible, periodontal disease has often already progressed past the point of easy intervention. Salivary diagnostics provides quantitative microbial information that complements clinical examination and radiographic findings, and without the guesswork that comes with relying on symptoms alone.
Systemic Risk Factors
Detects oral bacteria associated with periodontal disease and studied for their relationship with systemic health. Scientific research has identified associations between periodontal pathogens and conditions such as cardiovascular disease, diabetes, and Alzheimer's disease. The UniquePerioSignature™ Panel provides quantitative molecular data to support comprehensive periodontal assessment and individualized patient management by qualified healthcare professionals.
AI-assisted Clinical Decision Support
Every report includes AI-assisted interpretive guidance based on each patient's quantitative microbial profile. Personalized clinical insights and supporting scientific references help qualified healthcare professionals make evidence-informed decisions for individualized periodontal assessment and treatment planning. AI-generated insights are intended to support-not replace-the independent clinical judgment of licensed healthcare professionals.
Clinical applications
Built for your diagnostic workflow
Early Identification
Spot oral dysbiosis and disease risk before symptoms progress.
Tailored Care Strategies
Build periodontal and preventive plans around each patient's actual microbial profile.
Assess Oral Health Ecosystem
Track effectiveness over time with measurable, repeatable data.
Oral-Systemic Connection
Support the conversation between oral health and whole-body health with your patients
Disclaimer: The UniquePerioSignature™ Panel is intended for use by qualified healthcare professionals. Test results should be interpreted together with clinical findings, patient history, and other diagnostic information. This laboratory-developed test (LDT) is performed in a CLIA-certified, high-complexity laboratory and has not been cleared or approved by the U.S. Food and Drug Administration.